Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Cheng Lee

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Liver Cancer|December 24, 2021
Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after ResectionI-Cheng Lee, Jo-Yu Huang, Ting-Chun Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 24, 2023
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver diseaseChao Sun, George Boon-Bee Goh, Wan-Cheng Chow, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2020
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver diseaseXinrong Zhang, George B-B Goh, Wah-Kheong Chan, et al.
Journal of Viral Hepatitis|January 6, 2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia studyYong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, et al.
Medicine|August 13, 2015
Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis BI-Cheng Lee, Cheuk-Kay Sun, Chien-Wei Su, et al.
BMC Cancer|October 24, 2025
Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learningPei-Chang Lee, Po-Yu Li, Cheng-Yun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 StudyNai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Hepatology (Baltimore, Md.)|December 3, 2024
Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgeryRex Wan-Hin Hui, Keith Wan-Hang Chiu, I-Cheng Lee, et al.
Hepatology International|February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablationChing-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Liver Cancer|December 24, 2021
Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after ResectionI-Cheng Lee, Jo-Yu Huang, Ting-Chun Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 24, 2023
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver diseaseChao Sun, George Boon-Bee Goh, Wan-Cheng Chow, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2020
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver diseaseXinrong Zhang, George B-B Goh, Wah-Kheong Chan, et al.
Journal of Viral Hepatitis|January 6, 2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia studyYong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, et al.
Medicine|August 13, 2015
Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis BI-Cheng Lee, Cheuk-Kay Sun, Chien-Wei Su, et al.
BMC Cancer|October 24, 2025
Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learningPei-Chang Lee, Po-Yu Li, Cheng-Yun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 StudyNai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Hepatology (Baltimore, Md.)|December 3, 2024
Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgeryRex Wan-Hin Hui, Keith Wan-Hang Chiu, I-Cheng Lee, et al.
Hepatology International|February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablationChing-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Pageof 7